Clinical Efficacy of L-Ornithine–L-Aspartate in the Management of Hepatic Encephalopathy
- 1 January 2002
- journal article
- review article
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 17 (4) , 453-462
- https://doi.org/10.1023/a:1021934607762
Abstract
The clinical efficacy of both oral and parenteral L-ornithine–L-aspartate (OA) was confirmed by randomized, placebo-controlled, double-blind studies in patients with manifest hepatic encephalopathy...Keywords
This publication has 15 references indexed in Scilit:
- Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind studyJournal of Hepatology, 1998
- Effects of ornithine aspartate on plasma ammonia and plasma amino acids in patients with cirrhosis. A double-blind, randomized study using a four-fold crossover designJournal of Hepatology, 1993
- Hyperammonaemia causes many of the changes found after portacaval shuntingBiochemical Journal, 1990
- Skeletal muscle and whole-body protein turnover in cirrhosisClinical Science, 1990
- Functional hepatocyte heterogeneityEuropean Journal of Biochemistry, 1989
- Ammonia and glutamine metabolism in human liver slices: new aspects on the pathogenesis of hyperammonaemia in chronic liver diseaseEuropean Journal of Clinical Investigation, 1988
- Hepatocyte heterogeneity in ammonia metabolism: Impairment of glutamine synthesis in CCl4 induced liver cell necrosis with no effect on urea synthesisChemico-Biological Interactions, 1984
- Hepatocyte Heterogeneity in Glutamine and Ammonia Metabolism and the Role of an Intercellular Glutamine Cycle during Ureogenesis in Perfused Rat LiverEuropean Journal of Biochemistry, 1983
- [Influence of ornithine aspartate on the experimentally induced hyperammoniemia. Clinico-experimental study].1976
- [Clinical aspects of acute liver insufficiency].1958